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ABSTRACT The yeast mitochondrial histone protein HM
is required for maintenance of the mitochondrial genome, and
disruption of the gene encoding HM (HIMI/ABF2) results in
formation of a respiration-deficient petite mutant phenotype.
HM contains two homologous regions, which share sequence
similarity with the eukaryotic nuclear nonhistone protein,
HMG-1. Experiments with various deletion mutants of HM
show that a single HMG domain ofHM is functional and can
restore respiration competency to cells that lack HM protein
(himl mutant cells). The gene encoding the putative yeast
nuclear HMG-1 homolog, the NHP6A protein, can functionally
complement the himl mutation. These results suggest that the
HMG domain is the basic unit for the function of HM in
mitochondria and that the function of HMG-1 proteins in the
nudeus and HM in the mitochondrion may be equivalent.
The compaction of nuclearDNA is achieved at the first level
by formation of the nucleosomes in which DNA is wrapped
twice around the octameric complex of histones (1). In
bacteria there is a histone-like protein named HU, which is
an abundant DNA-binding protein capable of introducing
negative supercoil turns into relaxed circularDNA in vitro (2,
3). HU also forms a beaded nucleosome-like structure with
DNA (2, 4). The functional homology between HM and HU
in vivo (5) suggests that the mitochondrial DNA may also be
assembled into a nucleosome-like structure in mitochondria.
Caron et al. (6) first purified and characterized the yeast
mitochondrial histone-like protein HM and showed that it is
present in approximately the same mass as the mitochondrial
DNA and is able to introduce supercoil turns into circular
relaxed DNA. They suggested thatHM may play a structural
role in organization of the mitochondrial genome (6). We
purified the HM protein and cloned the gene and designated
it HIM) (5). The gene encodes the same protein as the yeast
DNA-binding protein ABF2, which was purified on the basis
of its higher binding affinity for a nuclear autonomous-
replicating sequence than for nonspecific DNA sequences
(7). Disruption of the HIM) (ABF2) gene in yeast leads to the
loss of mitochondrial DNA and produces a respiration-
deficient petite phenotype (5, 7). HM (ABF2) is encoded by
a nuclear gene and contains two domains that have significant
sequence similarity to a region of the eukaryotic nuclear
nonhistone protein HMG-1 (5, 7). Parisi and Clayton (8)
reported a human mitochondrial transcription factor (mtTF1)
that also has two HMG domains. Like HM, mtTF1 intro-
duces negative supercoils into relaxed circular DNA in vitro
(5, 6, 9, 10). The Xenopus laevis mitochondria also contain a
DNA-binding protein (mtDBP-C), which supercoils DNA
(11), and the N-terminal sequence has homology to HMG-1
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proteins (12). Therefore, it appears that the mitochondria of
different species have a similar HMG-1-like protein.
HMG-1 proteins are abundant nonhistone proteins in the
cell nucleus (13). However, their cellular functions remain
poorly defined (13). The primary sequence of HMG-1 pro-
teins is well conserved between species and usually consists
of two HMG domains and a C-terminal acidic tail domain
(13). The putative yeast HMG-1 proteins NHP6A and
NHP6B contain one HMG box and no acidic tail domain (14).
Several transcription factors containing HMG domains have
recently been discovered and indicate a widespread use of
this DNA-binding domain among proteins for DNA binding
and bending (15).
In this report, we investigated the role of the HMG
domains of HM in vitro and in yeast mitochondria by pro-
ducing various deletion mutants ofHM. Here we report that
each of the two HMG domains ofHM is functional in vivo.
In support of the major role of the HMG domain of HM, we
found that the NHP6A gene encoding the putative yeast
nuclear HMG-1 protein can complement the him) mutation.
The HM and HMG-1 proteins are probably evolved from a
common ancestral gene and may serve common functions in
the mitochondrion and the nucleus, respectively.
MATERIALS AND METHODS
Saccharomyces cerevisiae Strains. The generation ofthe him)
mutant strain TM144-15d (MATa him:: URA3 ade2-1 ura3-1
his3-11,15 trpl-l leu2-3,112) and wild-type strain TM144-15a
(HIM)) was described (5). The strains created by transforma-
tion of TM144-15d with plasmids are as follows: TM164
(pRS314G), TM165 (pGal-HIM1), TM166 (pGal-HIM1AC),
KLR11 (pGal-HIM1AN), KLR12 (pGal-HIM1A1-27), KLR13
(pGal-HIM1ACA1-27), KLR15 (pGal-HIMLACA17-27),
KLR16 (pGal-mNHP6A), and KLR40 (pGAL-nNHP6A).
Plasmid Construction. For expression ofthe mature form of
HM and deletion mutants in Escherichia coli, the appropriate
HIM) sequences were amplified from yeast genomicDNA by
PCR or recombinant PCR (16) and ligated into the Stu I site
downstream ofthe maltose-binding protein gene (malE) in the
plasmid pMALc (New England Biolabs). For expression in
yeast, HIM) and deletion mutants were fused to the HIM)
presequence by recombinant PCR and inserted in the Cla I
site downstream of the GALIO promoter in a yeast shuttle
vector pRS314G (TRPI, CEN6, ARS4; see ref. 5). For
expression of NHP6A in E. coli, the NHP6A gene (14) was
obtained by amplification of yeast genomic DNA by PCR and
ligated into pMALc. For targeting NHP6A to the mitochon-
dria, the HIM) presequence (5, 7) was fused with the NHP6A
gene before inserting into pRS314G. We also constructed a
plasmid containing the NHP6A gene without the HIM)
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presequence (pGAL-nNHP6A). All DNA sequences were
verified by the dideoxynucleotide chain-termination se-
quencing method (17).
Expression of the Mutant HM Proteins and NHP6A in E.
coli. HM, mutant HM proteins, and NHP6A were expressed
as fusion proteins with maltose-binding protein (MBP) in E.
coli strain XL1-Blue and purified by affinity chromatography
on an amylose column according to a protocol provided by
New England Biolabs. The fusion proteins were cleaved with
Factor Xa, and HM (or NHP6A) was further purified by
chromatography on a Bio-Rex 70 (Bio-Rad) column. The
purity ofthe proteins was confirmed by SDS/PAGE. Most of
the proteins produced a single band on the gel; some,
however, also contained some MBP protein. MBP, however,
does not bind to DNA or interfere with the binding ofHM to
DNA (data not shown). The concentration of HM was
determined by acid turbidity assay: 40 ,.l of protein solution
and 40 pl of 50%o trichloroacetic acid were mixed and
incubated at room temperature for 5 min; the turbidity
formed was determined at 400 nm and compared with those
obtained with known amounts of calf thymus histone Hi.
DNA Mobility-Shift Assay. The reaction mixture (20 ul)
included various amounts ofHM or the mutant proteins and
5 fmol of 32P-labeled double-stranded DNA fragment (the
sequence is AATTCGAGCTCGGTACCCCACTGC-
CCAGTCAAGTGTTCCTTGAACAGTAGGGATCCT) in
10 mM Tris HCl, pH 7.5/50 mM NaCl/10% (vol/vol) glyc-
erol/i mM EDTA/1 mM dithiothreitol. This DNA sequence
contains 30 bp of a rat thyroglobulin promotor sequence
flanked by 27 bp ofpUC18 polylinker sequence and was used
here because it was conveniently available in our laboratory
and not for any reason pertaining to its origins. It has been
shown that HM (ABF2) binds to DNA nonspecifically (9).
The mixture was incubated at room temperature for 30 min
and loaded onto a 6% polyacrylamide gel buffered with 22.5
mM Tris base/22.5 mM boric acid/0.625 mM EDTA. After
electrophoresis, the gel was dried and exposed to an x-ray
film.
DNA Supercoiling Assay. Each incubation mixture (20 .ld)
contained 200 ng of pBR325 plasmid DNA and various
amounts of HM or the mutant proteins and 2 units of
topoisomerase I in 10 mM Tris HCl, pH 8.0/1 mM EDTA/
100 mM NaCl and incubated at 37°C for 30 min and then
stopped by addition of 5 Al of 1% SDS/0.25% bromophenol
blue/25% glycerol. DNA was then analyzed by electropho-
resis on 1% agarose gel in 40 mM Tris acetate/2 mM EDTA.
Restoration of Respiration Competency of himl Mutant
Cells by Mutant HM Proteins. Yeast plasmids containing the
HIM) gene or a HIM) mutant gene were introduced into the
him) mutant strain TM144-1Sd using the LiCl method mod-
ified from Ito et al. (18). The transformants were inoculated
into medium containing 2% glucose or 0.5% galactose plus
1.5% raffinose and grown until late logarithmic phase at 30°C.
The cells were plated onto YPGalGE or YPDGE plates (1%
yeast extract/2% Bactopeptone/3% glycerol/2% ethanol/
0.1% galactose forYPGalGE or 0.1% glucose for YPDGE) (5,
19) and incubated at 37°C (5).
Preparation of Mitochondria. All yeast strains transformed
with plasmid were grown in synthetic complete (SC) medium
(without tryptophan and uracil) containing 2% galactose or
2% glucose (19) until stationary phase at 30°C and harvested
by centrifugation at 3600 x g (Sorvall SA600 rotor). The
spheroplasts were prepared by incubation with Zymolyase-
20T (0.625 mg/ml) in S buffer (1 M sorbitol/10mM Pipes, pH
6.5) and washed in S buffer and then suspended in 250 mM
sucrose/i mM EDTA/10 mM Pipes, pH 6.5, and homoge-
nized in a tight-fitting Dounce homogenizer. The cell debris
and nuclei were removed by centrifugation at 1500 x g for 5
min. The mitochondria were pelleted by centrifugation at
10,000 x g for 10 min. The differential centrifugation was
repeated once. The mitochondrial preparations were then
used for analysis of proteins by Western gel blotting without
further treatment.
Western Immunoblotting. The mitochondrial proteins frac-
tionated by SDS/PAGE were transferred to a nitrocellulose
membrane by electroblotting, and the membrane was probed
with polyclonal rabbit antibodies for HM protein (5) and
subsequent incubation with anti-rabbit IgG conjugated with
alkaline phosphatase according to a published protocol (20).
RESULTS
Construction of Deletion Mutants of HM Protein. Fig. 1
shows a schematic diagram of the domain structure of the
HM, HMG-1, and NHP6A proteins. The mature form ofHM
is 157 amino acids long (7). The two HMG domains in HM
reside between amino acid positions 17 and 84 and between
positions 90 and 157. The HMG domain may be considered
to consist of two subdomains, one region predicted to have
a 3-sheet structure and a second subdomain consisting oftwo
a-helices (21). An 11-amino acid stretch in the first subdo-
main is especially well conserved among HMG domain-
containing proteins and may be a DNA-binding motif (22).
The amino acid positions of these subdomains within the
protein sequences ofHM, HMG-1, and NHP6A are shown in
Fig. 1. To investigate the role of each HMG domain as well
as the subdomains in HM, we constructed various deletion
mutants ofHM as summarized in Fig. 2. To obtain the mutant
proteins for DNA-binding assays, the normal and mutant
HIM) genes without the HM presequence were fused to the
E. coli gene encoding MBP in an expression vector (pMALc).
The fusion proteins produced in E. coli were affinity purified
on an amylose column, and the MBP and HM proteins were
separated by cleavage with Factor Xa. HM was further
purified by chromatography on a Bio-Rex 70 column. The
purity ofHM and HM mutant proteins was confirmed by gel
electrophoresis.
DNA-Binding Activity of MutantHM Proteins. To study the
DNA-binding activity of HM proteins, we used the DNA
mobility-shift assay, which allows separation of DNA-
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FIG. 1. Schematic comparison of the domain structure of HM, HMG-1, and NHP6A proteins. Circle motifs correspond to a well-conserved
li-amino acid stretch within the HMG box; rectangle motifs correspond to the two tandem a-helix subdomains (21, 22). The hexagonal motif
with the negative signs around it (HMG-1) corresponds to the acidic domain of HMG-1 (13). Numbers correspond to amino acid positions
bordering each subdomain. Subdomains in the HMG box have not been designated based on a functional identification, but rather on the basis
of amino acid conservation in these regions and protein structural predictions.
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FIG. 2. Structure of mutant HM proteins. HM deletion mutants
retained the following amino acid regions: AC (1-89), AN (82-157),
A1-27 (28-157), ACA1-27 (28-89), ACA17-27 (1-16 and 28-89).
Numbers correspond to amino acid positions in the mature protein
(not the preprotein).
protein complexes from free DNA probe on nondenatured
polyacrylamide gels (23). HM binds to a short (57 bp) DNA
fragment and forms multiple DNA-protein complexes (Fig.
3A). Similar observations have been made with the E. coli
histone-like protein HU binding to short DNA fragments (24).
The first half molecule ofthe protein (HMAC), containing one
intact HMG domain, can bind to DNA and forms multiple
DNA-protein complexes as HM does (Fig. 3A). The com-
plexes formed with HMAC migrate faster than those formed
with HM due to its smaller size (9.3 vs. 18.6 kDa). The
formation of multiple complexes indicates that several mol-
ecules of either HM or HMAC can bind to each DNA
molecule. Protein crosslinking experiments showed that HM
(and HMAC) forms multimers in vitro (data not shown). All
of the other mutant HM proteins showed reduced DNA-
binding activity (Fig. 3A).
DNA Supercoiling Activity of Mutant HM Proteins. It has
been shown that binding of DNA to the octameric complex
of four core histones H2A, H2B, H3, and H4 at physiological
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FIG. 3. DNA-binding activity of mutant HM proteins. (A) DNA
mobility-shift assay. Recombinant HM and mutant HM proteins (20
ng) purified from E. coli were incubated with 32P-labeled DNA
fragment and applied on nondenatured polyacrylamide gel for elec-
trophoresis as described. (B) DNA supercoiling activity of mutant
HM proteins. Relaxed form of plasmid pBR325 (200 ng) was mixed
with increasing amounts of HM or mutant HM proteins (mass ratio
shown above each lane) in the presence of topoisomerase I as
described. After incubation, the reaction mixture was applied on
agarose gel and electrophoresed. S.C., supercoiled form; Rel.,
relaxed form.
into relaxed circular DNA, and the number of supercoil turns
introduced is roughly equal to that of nucleosomes formed
(25). The E. coli histone-like protein HU (2, 3) and yeast
mitochondrial histone HM (5, 6, 9, 10) also introduce nega-
tive supercoil turns into relaxed DNA. We have used this
system to assay for the introduction of supercoiled turns into
relaxed plasmid DNA by mutant HM proteins. HM converts
relaxed plasmid DNA into the supercoiled form maximally at
a protein/DNA ratio of 1 (ref. 6; Fig. 3B). HMAC, which
contains the first HMG domain in HM, can also introduce
supercoils into relaxed plasmid DNA and does so maximally
at a protein/DNA ratio of 1 (Fig. 3B). The mutant that retains
only the second HMG domain (AN; Fig. 3B) and all the other
mutant HM proteins (data not shown) did not have DNA-
supercoiling activity in vitro.
Restoration of Respiration Competency of himl Mutant
Cells by Mutant HM Proteins in Vivo. Growth of him) mutant
cells in the presence of a nonfermentable carbon source such
as glycerol, where a functional mitochondrial genome is
essential, is slower than wild-type cells at 30°C and com-
pletely blocked at 37°C (5). In the presence of fermentable
sugars such as glucose or galactose, where the function of the
mitochondrial genome is dispensable, the growth of him)
cells is unaffected at either temperature. Therefore, we
investigated the ability of the HM mutant proteins to restore
the growth of him] mutant cells on glycerol at 37°C. The
HIM] gene and the mutant HIM] genes were fused to the
GALJO promoter in a yeast shuttle vector (pRS314G) and all
genes contained the HIM) presequence to allow mitochon-
drial localization. These constructs permit production of the
HM proteins in the presence of galactose but not in the
presence of glucose. These plasmids were introduced into the
yeast strain TM144-15d (the him) mutant) and assayed for
their ability to restore respiration competency of the him)
mutant cells. The transformants were grown in medium
containing galactose or glucose until logarithmic phase. The
cells were then streaked on glycerol plates, which contained
a low concentration (0.1%) of either galactose (YPGalGE) or
glucose (YPDGE), and grown at 37°C. Fig. 4 (Upper) dem-
onstrates that the him) mutant cells containing the plasmids
encoding HM (pGAL-HIM1), the first HMG box of HM
(pGAL-HIM1AC), or the second HMG box of HM (pGAL-
HIM1AN) are dependent on a small amount ofgalactose to be
respiration competent, whereas the vector used in plasmid
construction cannot confer respiration competency to the
mutant cells. The HIM) wild-type strain can grow on either
medium. Due to the necessity of addition of galactose or
glucose for the induction or repression of the GALJO pro-
moter, respectively, there was a limited growth of the him)
mutant cells on either plate. These results show that the
mutant HM proteins containing an intact HMG domain
(HMAC or HMAN) is functional in mitochondria. On the
other hand, an HMG domain lacking the 11-amino acid
putative DNA-binding subdomain (mutant ACA1-27 in Fig. 4
Lower or ACA17-27; data not shown) was not functional in
vivo. However, HMA1-27, which lacks this subdomain but
has an intact second HMG box, is functional in vivo (Fig. 4
Lower). Western immunoblotting experiments with antibody
to HM protein confirmed that all of the mutant HM proteins
were present in yeast mitochondria when cells were grown in
the presence of galactose but not glucose (data not shown).
Functional Complementation of himl Mutant Cells by the
Yeast NHP6A Gene. As shown in Fig. 1, the yeast nuclear
nonhistone protein NHP6A has oneHMG domain that shares
significant sequence similarity (45%) with the HMG domain
ofbovine HMG-1 protein (14). Therefore, we were interested
to determine whether NHP6A can substitute for HM in
mitochondria. First, we investigated the ability of the
NHP6A protein to supercoil DNA in vitro. The NHP6A
protein produced in E. coli (Fig. SA), like HM, supercoiled
5600 Biochemistry: Kao et al.
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FIG. 4. Restoration of respiration compe-
tency of him) mutant cells by mutant HM pro-
teins. The him) mutant yeast cells were trans-
formed with the yeast plasmid carrying HIM) or
mutant HIM) genes (with the HIM) prese-
quence) fused with the GALIO promoter. Cells
were grown in medium containing either glucose
or galactose until logarithmic phase and then
plated onto glycerol plates containing a small
amount (0.1%) of either glucose (YPDGE) or
galactose (YPGalGE) and incubated at 37°C.
HIM1 represents wild-type cells (TM144-15a),
and all the other strains represented in this figure
are him) cells carrying various mutant HIM)
genes (see Fig. 2 for the designation).
DNA maximally at a protein/DNA mass ratio of=1 (Fig. SB).
For expression in mitochondria, the NHP6A gene was fused
with the DNA sequence corresponding to the HM prese-
quence, the presumed mitochondrial localization signal (5, 7),
and placed behind the GALIO promoter (pGal-mNHP6A).
The him] mutant cells containing pGal-mNHP6A grew as
well as the mutant cells containing pGal-HIM1 on YPGalGE
but grew poorly on YPDGE (Fig. SC). The NHP6A gene
fused to the GALIO promoter without the HIM) prese-
quences fused to it (pGAL-nNHP6A) did not complement the
him) mutant cells (Fig. SC). This result demonstrates that
NHP6A can substitute for HM in yeast mitochondria, con-
verting respiration-deficient himl cells to respiration-
competent cells.
DISCUSSION
In this report, we have shown that either one ofthe twoHMG
domains of the yeast mitochondrial histone HM is functional
in mitochondria, being capable of restoring respiration com-
petency to the him) mutant cells. We also conclude that the
conserved 11-amino acid putative DNA-binding motif is an
essential component for the function of the HMG box ofHM
in vivo. The yeast nuclear nonhistone protein NHP6A, which
has significant sequence similarity to HMG-1 proteins and is
the putative yeast HMG-1 homologue, can also complement
the absence ofHM in vivo when the protein has the presumed
HM presequence to target its import to the mitochondrion.
Our attempt to produce human HMG-1 in yeast mitochondria
was unsuccessful due to the instability of the DNA sequence
during cloning and expression (data not shown).
It is not clear why the second HMG domain (AN) and the
mutant protein lacking the first 27 amino acids but containing
the intact second HMG domain (A1-27) can complementHM
in vivo but have neither DNA-binding nor DNA-supercoiling
activity in vitro. It is possible that correct folding of these
mutant HM proteins is facilitated in yeast cells but not when
they are overproduced in E. coli. This notion is supported by
the inefficient cleavage of the MBP-HMAN fusion protein by
the factor Xa protease in vitro. In this sense, the in vivo assay
system described in this report probably provides a more
realistic assessment of the protein regions important for the
function ofHM in mitochondria.
The role that HM or a half molecule of HM plays in
maintaining the mitochondrial genome is presently unclear.
The DNA supercoiling activity and the protein-protein in-
teractions ofHM may be involved in compaction as well as
maintenance ofDNA in mitochondria. It will be important to
investigate whether the HM protein forms multimeric com-
plexes or nucleosome-like structures on DNA as does the E.
coliHU protein, which is functionally homologous toHM (5).
It is also possible that HM is not the only protein required for
maintenance of the mitochondrial genome since the him)
mutant cells containing a functional mitochondrial genome
can be maintained in the presence of glycerol at 30°C (5).
Recently, the PIFI gene, a helicase-encoding gene, was
reported to be essential for maintenance of mitochondrial
DNA at 36°C and the pifl null mutants would not grow on
glycerol at this elevated temperature (26). These phenotypes
are also associated with him) mutant (5) and, considering the
topological effects that both proteins exert on DNA, may
indicate a relationship between PIF1 and HM proteins in
maintaining the mitochondrial DNA.
Biochemistry: Kao et al.
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FIG. 5. DNA supercoiling activity ofNHP6A protein and complementation of him) mutant. (A) Coomassie blue staining of purified NHP6A
protein after SDS/PAGE. Left lane, size markers (kDa); right lane, NHP6A. NHP6A protein was purified from E. coli cells expressing the
NHP6A gene in plasmid pMALc. (B) DNA supercoiling activity. Assay was carried out as described in Fig. 3. Mass ratios of NHP6A protein
to plasmid DNA are shown above the lanes. (C) Complementation of him) mutant by NHP6A. The him) mutant cells were transformed with
plasmids carrying the normal NHP6A gene (pGAL-nNHP6A) and the NHP6A gene fused to the HIM) presequence (pGAL-mNHP6A). Assay
was carried out as described in Fig. 4.
The fact that the HMG domains of HM and the nuclear
nonhistone protein NHP6A can complement HM in vivo
strongly suggests that HM and the nuclear HMG-1 proteins
are derived from a common ancestor gene during eukaryotic
evolution. We found that HM and the E. coli histone-like
protein HU can complement each other either in yeast
mitochondria or in E. coli, although the two proteins do not
share any sequence similarity (5). The HM and HU proteins,
however, share common properties: DNA-binding andDNA-
supercoiling activity (5). In view of the bacterial origin of
mitochondria, it is possible that the original mitochondrial
gene encoding an HU-like protein was lost during eukaryotic
evolution along with most of the mitochondrial genome, and
that an HMG-1-like protein encoded by a nuclear gene
replaced the function of an HU-like protein. An alternative
evolutionary path may have been taken by the chloroplast,
which also has bacterial origins (27). The chloroplast has an
abundant histone-like protein that is recognized by antibodies
to HU (28).
The ability of the NHP6A protein to functionally comple-
ment the loss of HM, as shown in this report, indicates that
the role of NHP6A protein in the nucleus may be similar to
the role of HM in mitochondria. And the recent finding of
functional homology between HM and E. coli HU (5) sug-
gests that HM, NHP6A, and HU may all serve similar
functions in their respective environments. It will be impor-
tant to investigate whether all three of these proteins can
complement each other in all three environments.
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